Diabetes and obesity are the paramount recurrent endocrine-metabolic disorders that are categorized by hyperglycemia and impaired insulin secretion and/or its action (Kiziltas et al., 2022; Mutlu et al., 2023). This evidence concerns the gene INS and diabetes mellitus.